Observe Medical's share offering subscription period concludes today

Observe Medical ASA announced the closing of the subscription period for its subsequent offering today, October 10, 2025, at 4:30 PM CEST. The offering, launched on September 25, 2025, involves up to 24,000,000 new shares. Subscription forms must be received by SB1 Markets AS, the manager, or registered online before the deadline. Unused subscription rights will expire without compensation.

Further details regarding the subsequent offering and subscription procedures are available in the prospectus dated September 25, 2025, on Observe Medical's investor relations website and SB1 Markets' transactions page. The announcement also contains important disclaimers, noting that it is not an offer for sale in jurisdictions such as Australia, Canada, Hong Kong, Japan, South Africa, or the United States.

Observe Medical, a Nordic medtech company based in Oslo, Norway, specializes in developing and marketing innovative medtech products globally, particularly in urine measurement and ultrasound. The company aims to improve patient welfare, clinical data accuracy, and health economics. This offering is part of the company's growth strategy.